Results of a first-in-human phase I study of the ALK inhibitor LDK378 in advanced solid tumors

Abstract: 1757
Congress: ESMO 2012
Type: Abstract
Topic: Developmental therapeutics
Authors: A.T. Shaw1, R. Camidge2, E. Felip3, S. Sharma4, D.S.W. Tan5, D. Kim6, T. De Pas7, J.F. Vansteenkiste8, A. Santoro9, G. Liu10, M. Goldwasser11, D. Dai12, A.L. Boral11, R. Mehra13; 1Boston, MA/US, 2Denver/US, 3Barcelona/ES, 4Salt Lake City/US, 5Singapore/SG, 6Seoul/KR, 7Milano/IT, 8Leuven/BE, 9Rozzano/IT, 10Toronto/CA, 11Cambridge, MA/US, 12East Hanover, NJ/US, 13Philadelphia/US